AstraZeneca
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 months.
- Its last 4 Sell calls were actually followed by a +4% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -1.9% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Anonymous reader poll. Unscientific, not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 163.95
- Open
- 166.96
- Day range
- 166.66 - 168.54
- Avg price
- 167.89
- Volume
- 873.04K
- Turnover
- 146.57M
- Turnover ratei
- 0.06%
- Volume ratioi
- 1.27
- Amplitudei
- 1.15%
- 52-week rangei
- 152.40 - 209.11
Valuation
- P/Ei
- 25.75
- P/E (TTM)i
- 25.21
- P/Bi
- 5.19
- EPSi
- 6.54
- Book value / shi
- 32.43
- Net profit
- 10.14B
- Net assets
- 50.29B
Share structure
- Market cap
- 261.23B
- Float capi
- 259.86B
- Shares out
- 1.55B
- Float sharesi
- 1.54B
Dividend & listing
- Div yield (TTM)i
- 1.88%
- Dividend (TTM)
- 3.17
- Listing date
- 1970-01-01
19.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-116.86M net over the window
Short interest
- Shares short
- 2.62M
- % of floati
- 0.17%
- Days to coveri
- 1.00
- As of
- 2026-09-30
Frequently asked questions
What is the current stock price of AstraZeneca (AZN)?
AstraZeneca last traded at 168.44. The quote on this page refreshes every few seconds while US markets are open.
What is AstraZeneca's market cap?
About 261.23B.
What is the P/E ratio of AstraZeneca?
The trailing twelve-month P/E is 25.21, below its own 5-year average of 90.73 — toward the bottom of its historical range (14.18% percentile). See the Valuation tab for the full history.
Does AstraZeneca pay a dividend?
Yes. The trailing dividend yield is 1.88%. The 2025 payout was up 49.0% from 2024. See the Dividends tab for the full payment history.
Is AstraZeneca a buy according to analysts?
The consensus of 15 analysts is a Buy rating, with an average 12-month price target of 212.28, which implies 26.0% upside from the current price. This is not investment advice.
What is AstraZeneca's StockVane Quant Rating?
The StockVane Momentum strategy currently rates AstraZeneca a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-20 10:50:14 · For reference only, not investment advice and not tailored to your situation.
AstraZeneca discussion 0 comments